ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,459.10
1.11%
US Tech 100
18,514.40
1.00%
Dow Jones
40,589.34
1.64%
Brent Oil
79.745
-2.20%
Bitcoin
67,952.27
3.29%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Ab Science (AB) Quote

Ab Science

Ab Science (AB)

AllianceBernstein Holding LP
1.032
-0.008
(-0.77%)
Closed July 26 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.032
Bid
1.028
Ask
1.062
Volume
18,267
1.03 Day's Range 1.052
1.002 52 Week Range 4.465
Market Cap
53.737M
Previous Close
1.04
Open
1.034
Last Trade
58
@
1.032
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
136,754
Shares Outstanding
52,071,069
Dividend Yield
-
PE Ratio
-4.47
Earnings Per Share (EPS)
-0.23
Revenue
970k
Net Profit
-11.99M

About Ab Science

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.ab-science.com
Headquarters
Paris, Paris, Fra
Founded
1970
Ab Science is listed in the Pharmaceutical Preparations sector of the Euronext with ticker AB. The last closing price for Ab Science was 1.04 €. Over the last year, Ab Science shares have traded in a share price range of 1.002 € to 4.465 €.

Ab Science currently has 52,071,069 shares outstanding. The market capitalization of Ab Science is 54.15 € million. Ab Science has a price to earnings ratio (PE ratio) of -4.47.

AB Latest News

More News

AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19

AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19 COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE DES RESULTATS POSITIFS DE SON ETUDE DE PHASE...

July 08 2024
GlobeNewswire Inc.

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL...

June 28 2024
GlobeNewswire Inc.

AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024

AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024 COMMUNIQUE DE PRESSE RESULTATS DE L’ASSEMBLEE GENERALE MIXTE DU 26 JUIN 2024 Paris, 27 juin 2024, 10h15 Les...

June 27 2024
GlobeNewswire Inc.

AB Science fournit un résumé de la conférence virtuelle qui s'est tenue le 30 mai 2024, faisant le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

AB Science fournit un résumé de la conférence virtuelle qui s'est tenue le 30 mai 2024, faisant le point sur la demande d'autorisation de mise sur le marché conditionnelle du...

May 31 2024
GlobeNewswire Inc.

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE...

May 29 2024
GlobeNewswire Inc.

AB Science communique un rectificatif sur les comptes consolidés au 31 décembre 2023

AB Science communique un rectificatif sur les comptes consolidés au 31 décembre 2023          COMMUNIQUE RECTIFICATIF COMMUNIQUE RECTIFICATIF SUR LES COMPTES CONSOLIDES AU 31 DECEMBRE 2023...

May 17 2024
GlobeNewswire Inc.

AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités

AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités          COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS...

May 15 2024
GlobeNewswire Inc.

AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036

AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036 COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE...

May 13 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.05-4.621072088721.0821.091.02179801.05273204DE
4-0.124-10.72664359861.1561.21.016585121.08362178DE
12-0.868-45.68421052631.92.2951.0021367541.51407453DE
26-2.778-72.91338582683.8141.0021341492.02857692DE
52-3.008-74.45544554464.044.4651.0021537242.63305037DE
156-14.548-93.376123234915.5815.581.0021036935.63377287DE
260-3.368-76.54545454554.421.751.0021482408.44789973DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CGTXCognition Therapeutics Inc
$ 3.46
(45.99%)
4.09M
RNAZTransCode Therapeutics Inc
$ 0.36
(21.79%)
5.93M
NAMSNewAmsterdam Pharma Company NV
$ 22.13
(17.34%)
16.61k
TCTuanChe Ltd
$ 1.93
(16.97%)
640
YIBOPlanet Image International Ltd
$ 3.38
(15.95%)
50.1k
VTVTvTv Therapeutics Inc
$ 12.0634
(-43.10%)
25.22k
CEROCERo Therapeutics Holdings Inc
$ 0.1955
(-23.63%)
1.93M
TGLTreasure Global Inc
$ 1.436
(-22.38%)
46.74k
LUXHLuxUrban Hotels Inc
$ 0.1547
(-19.01%)
1.21M
JCSEJE Cleantech Holdings Limited
$ 1.1001
(-12.69%)
675
SLNASelina Hospitality PLC
$ 0.0262
(-12.67%)
16.66M
RNAZTransCode Therapeutics Inc
$ 0.36
(21.79%)
5.93M
CGTXCognition Therapeutics Inc
$ 3.46
(45.99%)
4.09M
TLTiShares 20 plus Year Treasury Bond
$ 92.98
(-0.01%)
3.9M
NVDANVIDIA Corporation
$ 113.00
(-0.05%)
2.44M

Discussion

View Full Feed
williamssc williamssc 55 seconds ago
If there was to be something new from Dr. Sabbagh a release would come before he speaks Sunday.
AVXL
DewDiligence DewDiligence 1 minute ago
More on the same story—(from Bloomberg):

https://finance.yahoo.com/news/3m-boosts-profit-forecast-ceo-105728844.html
MMM
CatfishHunter CatfishHunter 2 minutes ago
Correct. Company just confirmed with me clock started on June 28th and day 30 is tomorrow.
RDGL
DewDiligence DewDiligence 2 minutes ago
3M—More on the same story—(from Bloomberg):

https://finance.yahoo.com/news/3m-boosts-profit-forecast-ceo-105728844.html
price_and_volume price_and_volume 3 minutes ago
My post referenced the 8-K.

Yours did not.

No big deal, price-action reflects what insiders actually know.

ihub reflects what hopeful pumpers & punters wish for.

I hope the 2nd group gets what they want, despite what the 1s group knows.
VXIT
janice shell janice shell 3 minutes ago
And that makes it worse.
getmoreshares getmoreshares 3 minutes ago
DEI definition: https://x.com/TheyCallMeDoc1/status/1816953713052803178
janice shell janice shell 3 minutes ago
And was it a recent exchange? Or from some years ago? As I said, it seems to me they've recovered from the inanity of believing "you" is always specifically directed, rather than just a reference to "other people here".
FlyFishingStocks FlyFishingStocks 4 minutes ago
"Stay with the program"? What's that supposed to mean? So are you saying Alex Denner (Sarissa) involvement had nothing to do with a -65% drop in the share price while the Bio index rose +65%. How is that "squirming past the facts? Do I need to remind you PRICE IS KING... PRICE IS FACT!
AMRN
THall THall 4 minutes ago
Why do you continue to post false and misleading information? The warrants expired in 2023. Please post the 8k showing new warrants were issued or a form 4.

https://investorshub.advfn.com/uimage/uploads/2024/7/26/ayttnScreenshot_2024-07-26_4.56.28_PM.png
RSPI
jobynimble jobynimble 4 minutes ago
Scary that we think alike, my first small sell for SWIN is $30, lol…
Rhodan Rhodan 4 minutes ago
GTFU
TGLO
dude abides dude abides 4 minutes ago
They have to renew this every 3 years - this is a formality.

$33 mil left with Roth and $6 mil left with Lincoln.
LWLG
VeronicaFox VeronicaFox 5 minutes ago
Yep, you brought it up how many times today? lol! Do you remember all the totally false nonsense you’ve told about others? I have a list of over 40 things you’ve said that were 100% UNTRUE. < tsk tsk >

You said the CEO had been investigated by the SEC, exact words:
the CEO o
KEGS
4retire 4retire 5 minutes ago
NVDA has always been a long term investment. Traders make a few bucks, investors make mega bucks.
NVDA
janice shell janice shell 5 minutes ago
And when mods are posting on the board as much or more than users of the board, that kind of takes away from their duties to moderate the board, IMHO.

I disagree. The fact that they're posting on the board, and not just going through and batch reading the Manage page, means they actua
Chartmaster Chartmaster 6 minutes ago
Hey Clay, good to hear from you, been a while, miss the chart video's, what's your thoughts on HIRU?
HIRU
DewDiligence DewDiligence 6 minutes ago
Correction—3M's updated 2024 non-GAAP EPS guidance was an increase of $0.20 at the low end from $6.80 to $7.00. The high end of the guidance range, $7.30, is unchanged.
vein vein 6 minutes ago
I think we are buying polariton
LWLG
Mavlo77 Mavlo77 6 minutes ago
Only good news is that a reverse split usually tanks the share price in the aftermath of the split. Investors hate R/S. Well, in this case we’re already at the floor so there isn’t too much damage that can be done price wise. Since they let the share price fall to .0001 I feel like a buy back would
KATX
noradio noradio 6 minutes ago
I hear yah, my guess is the MM's have sold a substantial amount of naked shares here. They might have got spooked when they realized how large this merger might be, that's why this is the first OTC stock Clay has posted on since 2021. He said he got a tip and that's why he popped in here... please!
HIRU
tmcfo tmcfo 6 minutes ago
The real question is , are all those cars in the parking lot owned by employees who work for movement or velocity..
MVNT
Fire_starter Fire_starter 6 minutes ago
SOUND ALL ALARMS SOUND ALL ALARMS BREAKTHROUGH🔥🔥🔥🔥🔥🔥🔥🔥🔥🔥
RNAZ
DewDiligence DewDiligence 6 minutes ago
Correction—3M's updated 2024 non-GAAP EPS guidance was an increase of $0.20 at the low end from $6.80 to $7.00. The high end of the guidance range, $7.30, is unchanged.
MMM

Your Recent History

EU
AB
Ab Science
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved